Pharmacy

Researchers from Australia have developed a pioneering inhaled spray designed to stop the onset of type 1 diabetes. The diabetes prevention spray vaccine is presently being put through clinical trials and has already produced positive results from mouse- based trials. 52 participants, all aged over 18, are taking part and all have early-stage type 1 diabetes. The nasal vaccine has shown to be successful in human type 1 diabetes, could also be tested with different vaccines for the prevention of other autoimmune diseases such as rheumatoid arthritis and multiple sclerosis Type 1 diabetes is caused when the immune system turns on the beta cells responsible for manufacturing insulin and, as a result, glucose levels in urine and blood surge. These patients are therefore generally prescribed a daily supply of insulin via injection, to bring glucose levels back down.